Showing results (151-160 of 285) with videos related to

Sort By:
Pageof 29
American Journal of Respiratory and Critical Care Medicine|April 5, 2017
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary DiseaseDavid A Lipson, Helen Barnacle, Ruby Birk, et al.
JCI Insight|July 24, 2020
Intrahepatic heteropolymerization of M and Z alpha-1-antitrypsinMattia Laffranchi, Emma Lk Elliston, Elena Miranda, et al.
Chest|July 21, 2009
Sex differences in emphysema and airway disease in smokersPat G Camp, Harvey O Coxson, Robert D Levy, et al.
Plos Biology|November 2, 2007
Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicityLeila M Luheshi, Gian Gaetano Tartaglia, Ann-Christin Brorsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2025
The mechanism of pathogenic α1-antitrypsin aggregation in the human liverIbrahim Aldobiyan, Emma L K Elliston, Narinder Heyer-Chauhan, et al.
Clinical Science (London, England : 1979)|May 12, 2009
alpha1-Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathiesUgo I Ekeowa, Bibek Gooptu, Didier Belorgey, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 11, 2019
Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT TrialAfisi S Ismaila, Nancy Risebrough, Melanie Schroeder, et al.
Respiratory Research|September 15, 2014
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiencyLaura Pini, Laura Tiberio, Narayanan Venkatesan, et al.
Molecular Biosystems|October 12, 2012
Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPDBaljit K Ubhi, Kian Kai Cheng, Jiyang Dong, et al.
Pageof 29